These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3625830)

  • 1. Controversies regarding urine testing.
    Dougherty RJ
    J Subst Abuse Treat; 1987; 4(2):115-7. PubMed ID: 3625830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of costs for testing a wide variety of drugs of abuse per urine specimen in a drug abuse urine screening program and frequent urine collections.
    Kaistha KK; Tadrus R
    J Chromatogr; 1975 Jun; 109(1):149-62. PubMed ID: 1138000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of drugs-of-abuse testing in urine under blind conditions: an AACC study.
    Frings CS; Battaglia DJ; White RM
    Clin Chem; 1989 May; 35(5):891-4. PubMed ID: 2720992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical issues in urinalysis of abused substances: report of the Substance-Abuse Testing Committee.
    Clin Chem; 1988 Mar; 34(3):605-32. PubMed ID: 3280166
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug testing in addicts: a comparison between urine, sweat, and hair.
    Kintz P
    Ther Drug Monit; 1996 Aug; 18(4):450-5. PubMed ID: 8857567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fake urine samples for drug analysis: hot, but not hot enough.
    Person NB; Ehrenkranz JR
    JAMA; 1988 Feb; 259(6):841. PubMed ID: 3336195
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of specimen collection is crucial in urine screening of drug dependent mothers and newborns.
    Halstead AC; Godolphin W; Lockitch G; Segal S
    Clin Biochem; 1988 Jan; 21(1):59-61. PubMed ID: 3345600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for drugs of abuse: effect of heat-treating urine for safe handling of samples.
    Wolff K; Shanab MA; Sanderson MJ; Hay AW
    Clin Chem; 1990 Jun; 36(6):908-10. PubMed ID: 2357832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance.
    Krock K; Pesce A; Ritz D; Thomas R; Cua A; Rogers R; Lipnick P; Kilbourn K
    Pain Physician; 2017 Nov; 20(7):E1107-E1113. PubMed ID: 29149155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicators.
    Fraser AD; Zamecnik J
    Ther Drug Monit; 2003 Dec; 25(6):723-7. PubMed ID: 14639059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation and use of urine screening for drug abuse.
    Saxon AJ; Calsyn DA; Haver VM; Delaney CJ
    West J Med; 1988 Sep; 149(3):296-303. PubMed ID: 3176489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance evaluation of four on-site drug-testing devices for detection of drugs of abuse in urine.
    Peace MR; Tarnai LD; Poklis A
    J Anal Toxicol; 2000 Oct; 24(7):589-94. PubMed ID: 11043664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-site drug testing.
    Drummer OH
    Bull Narc; 2005; 57(1-2):205-11. PubMed ID: 21338022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the use of urine, hair, sweat and saliva to detect drug use.
    Dolan K; Rouen D; Kimber J
    Drug Alcohol Rev; 2004 Jun; 23(2):213-7. PubMed ID: 15370028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved cost effective thin-layer detection techniques for routine surveillance of commonly abused drugs in drug abuse urine screening and proficiency testing programs with built-in quality assurance.
    Kaistha KK; Tadrus R
    J Chromatogr; 1983 Sep; 267(1):109-16. PubMed ID: 6630364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of drug testing as an early warning programme: the experience of the Republic of Korea.
    Chung H
    Bull Narc; 2005; 57(1-2):231-48. PubMed ID: 21338024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for drugs of abuse: which matrix, oral fluid or urine?
    Allen KR
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):531-41. PubMed ID: 21885472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulation of drug use and urine screening patterns.
    Crosby RD; Carlson GA; Specker SM
    J Addict Dis; 2003; 22(3):89-98. PubMed ID: 14621347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.